We found that phenanthriplatin treatment downregulated miR-378j more than cisplatin (Fig. 3a), which suggests that the monofunctional complex may signal via the TGF-β/MAPK/ERK pathway to promote anti-cancer effect. The gene discussed is TGFB1; the disease is cancer.